Iovance Biotherapeutics
IOVA
IOVA
241 hedge funds and large institutions have $1.45B invested in Iovance Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 82 increasing their positions, 85 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.63% less ownership
Funds ownership: 101.38% → 97.75% (-3.6%)
15% less capital invested
Capital invested by funds: $1.71B → $1.45B (-$256M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Holders
241
Holding in Top 10
–
Calls
$19.6M
Puts
$3.25M
Top Buyers
| 1 | +$9.99M | |
| 2 | +$8.53M | |
| 3 | +$8.41M | |
| 4 |
Renaissance Technologies
New York
|
+$7.75M |
| 5 |
FC
Finepoint Capital
Boston,
Massachusetts
|
+$6M |
Top Sellers
| 1 | -$35.1M | |
| 2 | -$20M | |
| 3 | -$17.6M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$15.1M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$14.8M |